---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-26-000014"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:49:21.061262+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolent Q4 2025 revenue $468.7M, net loss $429.1M; guides 2026 revenue up ~30%

## Summary
- Q4 2025 revenue $468.7M, full-year $1.876B. Net loss $429.1M Q4, $579.4M full year.
- Adjusted EBITDA $37.8M (8.1% margin) Q4; $151.2M (8.1% margin) full year.
- Performance Suite average members 6,482 for year; $900M new Performance Suite revenue for 2026.
- 2026 revenue growth guidance ~30%; first-half Adj. EBITDA pressured by reservering and membership declines.
- Medical expense ratio 90.2% Q4; 80.5% full year (excl. ECP 94.8% and 89.0%).

## SEC filing metadata
- accession: 0001628908-26-000014
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000014/0001628908-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000014/evh-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-26-000014
- JSON: https://secwatch.observer/filing/0001628908-26-000014.json
- Plain text: https://secwatch.observer/filing/0001628908-26-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.